# Scopolamine Treatment for Patients With Organophosphate Poisoning

> **NCT00389259** · NA · WITHDRAWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Neurotoxicity Syndromes

## Interventions

- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00389259
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-10
- **Primary completion:** —
- **Final completion:** 2009-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-04-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389259, "Scopolamine Treatment for Patients With Organophosphate Poisoning". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00389259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*